MFSD12 Knockout HCT 116 Cell Line
Cat.No.:
EDC07831
Species:
Human
Cell Name:
HCT 116
Gene:
MFSD12
Gene ID:
126321
Size:
1×10⁶cells
MFSD12 Knockout HCT116 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07831 |
|---|---|
| Product Name | MFSD12 Knockout HCT116 Cell Line |
| Species | Human |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Gene ID | |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene | MFSD12 |
| Gene Synonyms | C19orf28|PP3501|SLC59B1 |
| Summary |
Enables cysteine transmembrane transporter activity. Involved in cysteine transmembrane transport; pigment metabolic process involved in pigmentation; and regulation of melanin biosynthetic process. Located in lysosome and melanosome. Part of late endosome. [provided by Alliance of Genome Resources, Jul 2025]
|
| Digestion Time | 3 min |
| Associated Diseases | Colorectal Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | mcCoy5A+10% FBS |
| Freezing Medium | 90% FBS/complete culture medium+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying MFSD12 function, MFSD12 Knockout HCT 116 Cell Line or MFSD12 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying MFSD12 in a complementary cellular background for cross-validation of MFSD12-dependent phenotypes. The Knockout line in HCT 116 is appropriate for asking whether MFSD12 is required for lysosomal cysteine/cystine transport in a colorectal cancer epithelial background — MFSD12 functions are conserved across cell types, and HCT 116 provides a distinct genetic background for confirming context-independent MFSD12 functions. Overexpression is useful for studying MFSD12 in heterologous expression contexts.
For MFSD12 research, the EDITGENE MFSD12 Knockout in HCT 116 enables study of lysosomal cysteine/cystine transport in an epithelial cancer context. This product complements the parallel MFSD12 Knockout in HEK293 (also available); cross-background validation strengthens characterization of MFSD12-dependent phenotypes. Rescue with wild-type or transport-deficient MFSD12 enables structure-function studies. Lysosomal cysteine pool analysis and pheomelanin precursor metabolism assays serve as functional readouts.
What are the application scenarios for this model?
Primary applications:
• Cross-background validation: parallel analysis with the MFSD12 Knockout in HEK293 (also available) to confirm context-independent MFSD12 functions.
• Lysosomal cysteine transport: lysosomal cysteine quantification in colorectal epithelial cancer background.
• Epithelial cell-specific MFSD12 roles: characterization of MFSD12 functions distinct from canonical melanocyte/pigmentation contexts.
• Structure-function rescue: rescue with wild-type or transport-deficient MFSD12 for systematic functional dissection.
EDITGENE recommends this HCT 116-based model for cross-validation of MFSD12 functions; the parallel HEK293 KO is preferred for high-throughput structure-function studies.
Is this MFSD12 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. MFSD12 rescue experiments in HCT 116 are well-suited for cross-background validation:
• Construct design: use a codon-modified MFSD12 sequence with a small intracellular tag (FLAG, HA). Preserve MFS family 12-transmembrane topology.
• Lysosomal localization validation: confirm lysosomal membrane localization before functional assays.
• Cross-background comparison: rescue in HCT 116 alongside HEK293 enables confirmation of context-independent MFSD12 functions.
• Functional readout: rescue should restore lysosomal cysteine/cystine transport in the colorectal epithelial cancer context.
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download